Valereum PLC Appointment of Corporate Broker
12 Aprile 2024 - 8:00AM
RNS Regulatory News
RNS Number : 3347K
Valereum PLC
12 April 2024
The information contained within
this announcement is deemed by the Company to constitute inside
information as stipulated under the Market Abuse Regulation (EU)
No. 596/2014 as it forms part of UK domestic law by virtue of the
European Union (Withdrawal) Act 2018 ("MAR")
12/04/2024
Valereum Plc
("Valereum" or the
"Company")
Appointment of
Corporate Broker
The Board of Valereum Plc (AQSE: VLRM), the Gibraltar technology solutions &
markets group, is pleased to announce that it has appointed
Stanford Capital Partners Limited to act as the Company's sole
corporate broker with immediate effect.
The directors of the Company accept
responsibility for the contents of this announcement.
For more information, please visit the
Company's website at vlrm.com
Enquiries:
Valereum Plc
James Formolli, Chairman
Tel: +971 4584 6284
Stanford Capital Partners (Corporate
Broker)
Bob Pountney
Patrick Claridge
Tel: +44 23 3650 3650
First Sentinel Corporate Finance (AQSE
Corporate Adviser)
Brian Stockbridge
Tel: +44 20 3855 5551
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NEXEFLFFZZLXBBF
Grafico Azioni Valereum (AQSE:VLRM)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Valereum (AQSE:VLRM)
Storico
Da Gen 2024 a Gen 2025